Tyromolaradenate, a type of chemical common in certain types of snack foods, is inert in adults and only toxic to children with a rare neurological disorder. Unfortunately, tyromolaradenate is produced as a byproduct of industrial processes necessary for the manufacture of these snack foods. The FDA intends to protect public health by mandating that all snack foods containing tyromolaradenate clearly state so on their packaging. However, many children with this neurological condition are undiagnosed and current screening methods are somewhat unreliable. And food labels will only prove effective at protecting children who know they have the disease.
Which of the following, if performed by the FDA, could logically be expected to help the FDA overcome the problem with their plan to protect children susceptible to tyromolaradenate?